<DOC>
	<DOCNO>NCT01124773</DOCNO>
	<brief_summary>WHIMS-Y provide valuable information long-term effect risk cognitive impairment hormone therapy subset WHI participant WHI Hormone Trials . Following cessation study-prescribed HT cognitive function impairment assess .</brief_summary>
	<brief_title>Memory Study Youngest Women Enrolled Women 's Health Initiative Hormone Therapy ( HT ) Arm</brief_title>
	<detailed_description>The Women 's Health Initiative Memory Study Younger Women ( WHIMS-Y ) propose assess long-term impact random assignment postmenopausal hormone therapy ( equine estrogen alone combination medroxyprogesterone versus placebo ) among woman age 50-54 time randomization WHI hormone trial . Secondary objective relate consistency treatment effect across unopposed oppose therapy whether exists evidence grade relationship cognitive effect age administration , year menopause , baseline risk factor cognitive impairment .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Must enrol Women 's Health Initiative Extension Not enrol Women 's Health Initiative Extension</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>cognition</keyword>
	<keyword>memory</keyword>
	<keyword>hormone therapy</keyword>
</DOC>